Loading...
Rituximab — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Rituximab
2025-Q4
Comprehensive analysis of India’s rituximab export trade — suppliers, buyers, prices, routes, and every shipment record.
137
Shipments
$1.75M
Trade Value
35
Suppliers
42
Buyers
36
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/rituximab
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s rituximab trade — 2025-Q4
KEY TAKEAWAY
Rituximab 2025-Q4 exports total $1.7M across 36 countries, with DRREDDYS LABORATORIES LTD commanding 50.6% market share.
TOTAL SHIPMENTS
137
2025-Q4
EXPORT VALUE
$1.7M
FOB USD
TOTAL QUANTITY
24.0K
units shipped
INDIAN SUPPLIERS
35
unique exporters
GLOBAL BUYERS
42
unique importers
DESTINATIONS
36
countries
MEDIAN UNIT PRICE
$55.71
per unit
TOP-5 SHARE
93.9%
of total USD
BRANDED SHARE
73.7%
101 shipments
DOSAGE FORMS
7
product types
6 KEY FINDINGS
1
DRREDDYS LABORATORIES LTD is India's #1 Rituximab exporter with $883.4K (50.6% market share).→ §5, Indian Supplier Rankings
2
Rituximab reached 36 countries, with Russia as the top destination ($858.9K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 4071) — top 10 suppliers control 97.3% of exports.→ §5, Indian Supplier Rankings
4
95.2% of buyers (40 of 42) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Solution dominates (66.7%) across 7 dosage forms.→ §7, Price Benchmarks
6
35 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 DRREDDYS LABORATORIES LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian rituximab exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Rituximab report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial rituximab trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian rituximab suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Rituximab India trade report
Product scope
Rituximab
All variants merged — branded and generic formulations of rituximab
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
137
Every commercial rituximab trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $888.0K, Nov $693.9K, Dec $164.8K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$888.0K
Oct USD
8 shipments
2
$693.9K
Nov USD
-21.9% MoM
3
$164.8K
Dec USD
-76.3% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 21.9% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $888K, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $1.7M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $194K dip in Nov, $529K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $888K | 8 shipments |
| Nov | $694K | 68 shipments |
| Dec | $165K | 61 shipments |
| Q4 Total | $1.7M | 137 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Kenya held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: RELIANCE LIFE SCIENCES PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import rituximab from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Russia absorbs 49.2% of India’s 2025-Q4 rituximab trade ($858.9K). Beyond the top 10 destinations, 35 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 15 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 35 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much rituximab India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$444K
25.4% of trade
10 countries · 40 shipments
Europe
$861K
49.3% of trade
2 countries · 5 shipments
Americas
$259K
14.8% of trade
9 countries · 23 shipments
Africa
$183K
10.5% of trade
15 countries · 69 shipments
Fig 4.1 Russia is the #1 corridor ($859K) — 30 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian rituximab it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Russia | $859K | 2 | DRREDDYS LABORATORIES LTD | $858K | CHINTAN CHEMICALS | $1K | — | — |
| 2 | Lebanon | $306K | 10 | RELIANCE LIFE SCIENCES PVT LTD | $297K | RMPL PHARMA LLP | $9K | — | — |
| 3 | Peru | $177K | 4 | RELIANCE LIFE SCIENCES PVT LTD | $177K | — | — | — | — |
| 4 | Colombia | $66K | 1 | RELIANCE LIFE SCIENCES PVT LTD | $66K | — | — | — | — |
| 5 | Kenya | $56K | 29 | R.S. SURGIPHARM PVT LTD | $19K | RELIANCE LIFE SCIENCES PVT LTD | $16K | ASPIDA LIFE SCIENCES PVT LTD | $10K |
| 6 | Zimbabwe | $32K | 3 | RELIANCE LIFE SCIENCES PVT LTD | $25K | 3S PHARMACEUTICALS INDIA PVT LTD | $7K | — | — |
| 7 | Nepal | $31K | 2 | RELIANCE LIFE SCIENCES PVT LTD | $31K | — | — | — | — |
| 8 | Maldives | $26K | 2 | DRREDDYS LABORATORIES LTD | $26K | NU HOSPITALS PVT LTD | $447 | — | — |
| 9 | Botswana | $26K | 1 | RELIANCE LIFE SCIENCES PVT LTD | $26K | — | — | — | — |
| 10 | Sri Lanka | $24K | 7 | RELIANCE LIFE SCIENCES PVT LTD | $22K | PLEASANT EXPORTS | $2K | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 25.4% of USD — but Russia is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
49.2%
#1 country share
Russia alone
83.8%
Top 5 share
5 of 36 countries
96.9%
Top 15 share
Long tail of 21 countries = 3.1%
HHI 2872
Destination HHI
Highly concentrated
36
Countries served
Global pharma reach from India
15
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
35 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
DRREDDYS LABORATORIES LTD ($883.4K, 50.6% share) and RELIANCE LIFE SCIENCES PVT LTD ($677.1K) together control 89.3% of India’s 2025-Q4 rituximab trade. The top 5 suppliers hold 93.9%. 35 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian rituximab suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 DRREDDYS LABORATORIES LTD leads by $206K over RELIANCE LIFE SCIENCES PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: INVEX HEALTH PVT is #4 by value but #17 by volume.
Fig 5.2 RELIANCE LIFE SCIENCES PVT LTD also leads by shipment count (27) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: INVEX HEALTH PVT moves from #17 by volume to #4 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 35 rituximab suppliers split into strategic segments
KEY TAKEAWAY
9 suppliers (25%) generate 96.8% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 DRREDDYS LABORATORIES LTD and RELIANCE LIFE SCIENCES PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 96.8% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | DRREDDYS LABORATORIES LTD | 3 | 3 | $883K |
| 2 | RELIANCE LIFE SCIENCES PVT LTD | 2 | 10 | $677K |
| 3 | R.S. SURGIPHARM PVT LTD | 2 | 1 | $19K |
| 4 | RMPL PHARMA LLP | 1 | 4 | $35K |
| 5 | INVEX HEALTH PVT LTD | 1 | 1 | $23K |
| 6 | J.A. UNITED EXPORTS PVT LTD | 1 | 2 | $22K |
| 7 | PIRZE LIFECARE PVT LTD | 1 | 1 | $13K |
| 8 | ASPIDA LIFE SCIENCES PVT LTD | 1 | 1 | $10K |
| 9 | SANSKRUTI PHARMA | 1 | 1 | $9K |
| 10 | SUBHRA PHARMA PRIAVATE LTD | 1 | 1 | $7K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the rituximab manufacturing hubs
KEY TAKEAWAY
Hyderabad and Navi Mumbai Maharashtra together account for $1.3M of India’s 2025-Q4 rituximab trade.
Fig 5.5 Hyderabad (1 exporters, $883K) and Navi Mumbai Maharashtra (1 exporters, $437K) are India’s rituximab capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
93.9%
Top 5 share
5 of 35 suppliers
97.3%
Top 10 share
10 of 35 suppliers
96.8%
Top 25% share
9 suppliers = 97% USD
HHI 4071
Supplier HHI
Concentrated
35
Total suppliers
shipped Rituximab in 2025-Q4
20+ cities
Indian hubs
Hyderabad and Navi Mumbai Maharashtra lead
§5.2 Coming next: 3 exporter deep-dive profiles
Each of the top 3 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | RELIANCE LIFE SCIENCES PVT LTD | $677K |
| #2 | RMPL PHARMA LLP | $35K |
| #3 | VEA IMPEX (I) PVT LTD | $860 |
#2
EXPORTER PROFILE #1 OF 3
RELIANCE LIFE SCIENCES PVT LTD
Navi Mumbai Maharashtra · India’s #2 rituximab supplier by USD · 2025-Q4
2025-Q4 USD
$677K
38.8% market share
SHIPMENTS
27
avg $25K/ship
COUNTRIES
10
destination markets
BUYERS
12
11 single-sourced
BRANDED
100%
of shipments
DOSAGE FORMS
2
product types
TOP 10 DESTINATIONS
Lebanon is the #1 market at $297K (44% of trade), followed by Peru at $177K. 10 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Lebanon | $297K | 3 | 43.9% |
| 2 | Peru | $177K | 4 | 26.2% |
| 3 | Colombia | $66K | 1 | 9.7% |
| 4 | Nepal | $31K | 2 | 4.5% |
| 5 | Botswana | $26K | 1 | 3.8% |
| 6 | Zimbabwe | $25K | 1 | 3.8% |
| 7 | Sri Lanka | $22K | 5 | 3.2% |
| 8 | Kenya | $16K | 4 | 2.4% |
| 9 | Zambia | $10K | 2 | 1.4% |
| 10 | Dominican Republic | $7K | 4 | 1.1% |
MONTHLY TREND
Nov peaked at $616K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 55% of trade. Solution (45.3%) and others are secondary formulations.
TOP BUYERS · 11/11 LOCKED IN
11 of 11 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| LEVANT PULSE | Lebanon | $297K | ⚠ Locked |
| DROGUERIA MK LAB S.A | Peru | $177K | ⚠ Locked |
| LABORATORIOS LEGRAND S.A | Colombia | $66K | ⚠ Locked |
| PHARMACHEM PVT LTD | Nepal | $31K | ⚠ Locked |
| CENTRAL MEDICAL STORES… | Botswana | $26K | ⚠ Locked |
| PLANET PHARMACEUTICALS… | Zimbabwe | $25K | ⚠ Locked |
| Undisclosed buyer | Sri Lanka | $14K | N/A |
| GRIFFINS MEDICALS LTD | Zambia | $10K | ⚠ Locked |
| ABC PHARMA SERVICES (P… | Sri Lanka | $10K | ⚠ Locked |
| GALAXY PHARMACEUTICAL … | Kenya | $8K | ⚠ Locked |
#2
EXPORTER PROFILE #1 OF 3 — TRADE FLOW MAP
RELIANCE LIFE SCIENCES PVT LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 Lebanon absorbs $297K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 1 importers per destination.
#3
2025-Q4 USD
$35K
2.0% market share
SHIPMENTS
17
avg $2K/ship
COUNTRIES
4
destination markets
BUYERS
2
unique importers
BRANDED
82%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Turkey is the #1 market at $22K (62% of trade), followed by Lebanon at $9K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Turkey | $22K | 3 | 61.9% |
| 2 | Lebanon | $9K | 7 | 24.6% |
| 3 | Kenya | $2K | 3 | 6.8% |
| 4 | United Arab Emirates | $2K | 4 | 6.7% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $19K.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Lebanon | $34K | N/A |
| Undisclosed buyer | United Arab Emirates | $1K | N/A |
#3
EXPORTER PROFILE #2 OF 3 — TRADE FLOW MAP
RMPL PHARMA LLP — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P2.3 Turkey absorbs $22K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
#24
EXPORTER PROFILE #3 OF 3
VEA IMPEX (I) PVT LTD
Mumbai · India’s #24 rituximab supplier by USD · 2025-Q4
2025-Q4 USD
$860
0.0% market share
SHIPMENTS
6
avg $143/ship
COUNTRIES
3
destination markets
BUYERS
1
unique importers
BRANDED
100%
of shipments
DOSAGE FORMS
2
product types
TOP 3 DESTINATIONS
Antigua and Barbuda is the #1 market at $821 (95% of trade), followed by Somalia at $31. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Antigua and Barbuda | $821 | 2 | 95.5% |
| 2 | Somalia | $31 | 3 | 3.6% |
| 3 | Dominica | $8 | 1 | 0.9% |
MONTHLY TREND
Nov peaked at $821. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 50% of trade. Vial (49.9%) and others are secondary formulations.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Antigua and Barbuda | $860 | N/A |
#24
EXPORTER PROFILE #3 OF 3 — TRADE FLOW MAP
VEA IMPEX (I) PVT LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P3.3 Antigua and Barbuda absorbs $821 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
42 importers across 36 countries — who is buying Indian rituximab and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 94.4% of total USD. 95% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian rituximab. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 JSC R-PHARM is the #1 importer at $858K (49.1%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
95%
Single-source
40 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
5%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source rituximab from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Kenya 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| GOLD TREE PHARMACEUTIC… | ASPIDA LIFE SCIENCES… | $10K | $144.233 | Injection |
| GALAXY PHARMACEUTICAL … | RELIANCE LIFE SCIENC… | $8K | $97.047 | Injection |
| ABU AHMED | AMARI TRADE ALLIANCE… | $292.497 | $14.625 | Injection |
| MORAN PHARMACY LTD | M T MADON EXPORTS | $216.570 | $14.438 | Injection |
Sri Lanka 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ABC PHARMA SERVICES (P… | RELIANCE LIFE SCIENC… | $10K | $47.675 | Injection |
| ABC PHARMA SERVICES [P… | RELIANCE LIFE SCIENC… | $6K | $40.373 | Injection |
| THE ESSES PHARMACY (PV… | PLEASANT EXPORTS | $2K | $62.266 | Injection |
Russia 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| JSC R-PHARM | DRREDDYS LABORATORIE… | $858K | $370.762 | Solution |
| JSC GENERIUM | CHINTAN CHEMICALS | $1K | $59.932 | Injection |
Maldives 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| STATE TRADING ORGANIZA… | DRREDDYS LABORATORIE… | $26K | $127.888 | Injection |
| INDIRA GANDHI MEMOROAL… | NU HOSPITALS PVT LTD | $447.035 | $223.518 | Injection |
Zimbabwe 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PLANET PHARMACEUTICALS… | RELIANCE LIFE SCIENC… | $25K | $169.350 | Injection |
| FOR THE ORDER OF | 3S PHARMACEUTICALS I… | $7K | $88.025 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | JSC R-PHARM | Russia | $858K | $858K | Premium |
| 2 | LEVANT PULSE | Lebanon | $297K | $99K | Premium |
| 3 | DROGUERIA MK LAB S.A | Peru | $177K | $44K | Premium |
| 4 | LABORATORIOS LEGRAND… | Colombia | $66K | $66K | Premium |
| 5 | PHARMACHEM PVT LTD | Nepal | $31K | $15K | Mid |
| 6 | CENTRAL MEDICAL STOR… | Botswana | $26K | $26K | Mid |
| 7 | STATE TRADING ORGANI… | Maldives | $26K | $26K | Mid |
| 8 | PLANET PHARMACEUTICA… | Zimbabwe | $25K | $25K | Mid |
| 9 | PHARM MEDICAL POST | Eswatini | $23K | $23K | Mid |
| 10 | AL-NOOR FOR DRUGS & … | Yemen | $22K | $6K | Budget |
| 11 | BREVITEE INTERNATION… | Equatorial Guinea | $13K | $4K | Budget |
| 12 | GOLD TREE PHARMACEUT… | Kenya | $10K | $3K | Budget |
| 13 | GRIFFINS MEDICALS LTD | Zambia | $10K | $5K | Budget |
| 14 | ABC PHARMA SERVICES … | Sri Lanka | $10K | $10K | Budget |
| 15 | GALAXY PHARMACEUTICA… | Kenya | $8K | $4K | Budget |
| 16 | SEAN DOMINICAN SRL | Dominican Republic | $7K | $2K | Budget |
| 17 | FOR THE ORDER OF | Zimbabwe | $7K | $4K | Budget |
| 18 | ETEMAD MOSLEH LTD | Afghanistan | $7K | $3K | Budget |
| 19 | ABC PHARMA SERVICES … | Sri Lanka | $6K | $3K | Budget |
| 20 | R PHARMA | Malawi | $6K | $2K | Budget |
| 21 | FELICIA CARLOS DE AR… | Brazil | $4K | $4K | Budget |
| 22 | RENATO C LOZADA | Philippines | $4K | $1K | Budget |
| 23 | EHSAN COMERCIO GERL … | Angola | $2K | $2K | Budget |
| 24 | THE ESSES PHARMACY (… | Sri Lanka | $2K | $934.000 | Budget |
| 25 | SOVEREIGN SPEED FRA … | Germany | $2K | $585.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 DRREDDYS LABORATORIES LTD → JSC R-PHARM is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian rituximab prices vary by supplier, country and dosage form
KEY TAKEAWAY
Rituximab prices span 2224× ($0.192 → $428.13). The coefficient of variation is 1.13. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.192 | Lowest observed unit price |
| P5 | $0.689 | 5th percentile |
| P25 | $16.57 | 25th percentile (Q1) |
| Median | $55.71 | 50th percentile (Q2) |
| P75 | $74.03 | 75th percentile (Q3) |
| P95 | $161.76 | 95th percentile |
| Max | $428.13 | Highest observed unit price |
| Mean | $61.39 | Arithmetic average |
| CV | 113% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 PIRZE LIFECARE PVT LTD prices at $316.11/unit vs market median $55.71.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. RELIANCE LIFE SCIENCES Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. DRREDDYS LABORATORIES LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. INVEX HEALTH PVT Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. 3S PHARMACEUTICALS INDIA Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | NIVIRA EXPORTS | Brazil | Liquid | 6 | $4K | $739.86 | Specialty / small-batch |
| Dec 2025 | PIRZE LIFECARE P… | Equatorial Guinea | Injection | 5 | $2K | $428.13 | Sterile formulation premium |
| Dec 2025 | PIRZE LIFECARE P… | Equatorial Guinea | Injection | 20 | $9K | $428.13 | Sterile formulation premium |
| Oct 2025 | DRREDDYS LABORAT… | Russia | Solution | 2K | $858K | $370.76 | Specialty / small-batch |
| Oct 2025 | NU HOSPITALS PVT… | Maldives | Injection | 2 | $447.04 | $223.52 | Sterile formulation premium |
| Dec 2025 | RELIANCE LIFE SC… | Zimbabwe | Injection | 150 | $25K | $169.35 | Sterile formulation premium |
| Nov 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 10 | $2K | $168.24 | Sterile formulation premium |
| Nov 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 10 | $2K | $161.76 | Sterile formulation premium |
| Nov 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 10 | $2K | $161.76 | Sterile formulation premium |
| Nov 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 10 | $2K | $161.75 | Sterile formulation premium |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | RMPL PHARMA LLP | Turkey | Injection | 30 | $4.10 | $0.137 | Sterile formulation premium |
| Dec 2025 | J.A. UNITED EXPO… | Egypt | Injection | 166 | $31.95 | $0.192 | Sterile formulation premium |
| Dec 2025 | RELIANCE LIFE SC… | Dominican Republic | Injection | 50 | $13.86 | $0.277 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 200 | $103.42 | $0.517 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 300 | $178.39 | $0.595 | Sterile formulation premium |
| Dec 2025 | RELIANCE LIFE SC… | Dominican Republic | Injection | 100 | $66.51 | $0.665 | Sterile formulation premium |
| Dec 2025 | RMPL PHARMA LLP | Lebanon | Injection | 50 | $33.72 | $0.674 | Sterile formulation premium |
| Dec 2025 | VEA IMPEX (I) PV… | Somalia | Injection | 15 | $10.34 | $0.689 | Sterile formulation premium |
| Dec 2025 | VEA IMPEX (I) PV… | Somalia | Injection | 15 | $10.34 | $0.689 | Sterile formulation premium |
| Dec 2025 | VEA IMPEX (I) PV… | Somalia | Vial | 15 | $10.34 | $0.689 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship rituximab, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Rituximab leaves India through 8+ ports. The top 5 (HYDERABAD AIR, MUMBAI AIR (SAHAR), RAXAUL) handle 99.4% of total USD. AIR moves 98% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 HYDERABAD AIR handles $883K — top 8 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 MOSCOW DOMODEDOVO is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 98% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$1.7M
98.2% of USD · 97.8% of ships
ROAD
$31K
1.8% of USD · 1.5% of ships
ICD
$592
0.0% of USD · 0.7% of ships
Fig 8.3 The dominant corridor is HYDERABAD AIR → Air → Europe ($858K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Burkina Faso is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 2549).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Burkina Faso (HHI 10,000) is the most concentrated — Kenya (HHI 2,549) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| JSC R-PHARM | Russia | DRREDDYS LABORAT… | $858K | 1 | CRITICAL |
| LEVANT PULSE | Lebanon | RELIANCE LIFE SC… | $297K | 3 | HIGH |
| DROGUERIA MK LAB S.A | Peru | RELIANCE LIFE SC… | $177K | 4 | HIGH |
| LABORATORIOS LEGRAND… | Colombia | RELIANCE LIFE SC… | $66K | 1 | MEDIUM |
| PHARMACHEM PVT LTD | Nepal | RELIANCE LIFE SC… | $31K | 2 | MEDIUM |
| CENTRAL MEDICAL STOR… | Botswana | RELIANCE LIFE SC… | $26K | 1 | MEDIUM |
| STATE TRADING ORGANI… | Maldives | DRREDDYS LABORAT… | $26K | 1 | MEDIUM |
| PLANET PHARMACEUTICA… | Zimbabwe | RELIANCE LIFE SC… | $25K | 1 | MEDIUM |
Conclusion: 40 buyers depend on exactly one Indian supplier, representing $1.7M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Russia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lebanon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Peru | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Colombia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Zimbabwe | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Maldives | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Botswana | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Eswatini | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Turkey | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Yemen | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Equatorial Guinea | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Zambia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Russia | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Burkina Faso lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Russia (2 suppliers) | This Q | HIGH |
| A6 | Enter Lebanon (2 suppliers) | This Q | MED |
| A8 | Build Lebanon distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Russia tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Russia | Other | 2 | $859K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Lebanon | Other | 2 | $306K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Peru | Other | 1 | $177K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Colombia | Other | 1 | $66K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Zimbabwe | Africa | 2 | $32K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Nepal | Asia | 1 | $31K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Maldives | Asia | 2 | $26K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Botswana | Africa | 1 | $26K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Sri Lanka | Asia | 2 | $24K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Eswatini | Africa | 1 | $23K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Turkey | Other | 2 | $22K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Yemen | Other | 1 | $22K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Equatorial Guinea | Africa | 1 | $13K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Zambia | Africa | 1 | $10K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Burkina Faso | Africa | 1 | $9K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 137 2025-Q4 Rituximab shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/rituximab
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 137 2025-Q4 rituximab shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian rituximab shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
137
across all regions
TOTAL USD
$1.75M
2025-Q4 FOB value
UNITS
24.0K
tablets, capsules, etc.
SUPPLIERS
35
Indian exporters
BUYERS
42
global importers
COUNTRIES
36
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $183K (10.5%), spanning 15 countries.
35 Indian suppliers shipped to 42 buyers across 36 countries — average shipment value $13K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
15 countries · 69 shipments · $183K · 21 Indian suppliers · 19 buyers
SHIPMENTS
69
USD
$183K
COUNTRIES
15
SUPPLIERS
21
BUYERS
19
HHI
2,197
moderate
Top 15 destination countries in Africa
1
Kenya (30.4%)
$56K
2
Zimbabwe (17.8%)
$32K
3
Botswana (14.1%)
$26K
4
Eswatini (12.8%)
$23K
5
Equatorial Guinea (7.1%)
$13K
6
Zambia (5.2%)
$10K
7
Burkina Faso (4.7%)
$9K
8
Malawi (3.0%)
$6K
9
Egypt (1.6%)
$3K
10
Angola (1.3%)
$2K
11
Seychelles (0.9%)
$2K
12
Mali (0.5%)
$858.12
13
Cameroon (0.4%)
$663.44
14
Burundi (0.2%)
$326.38
15
Somalia (0.0%)
$31.01
Top 21 Indian suppliers into Africa
1
RELIANCE LIFE SCIENCES PVT LTD
$77K
2
INVEX HEALTH PVT LTD
$23K
3
R.S. SURGIPHARM PVT LTD
$19K
4
PIRZE LIFECARE PVT LTD
$13K
5
ASPIDA LIFE SCIENCES PVT LTD
$10K
6
SANSKRUTI PHARMA
$9K
7
SUBHRA PHARMA PRIAVATE LTD
$7K
8
3S PHARMACEUTICALS INDIA PVT LTD
$7K
9
MATHI ASSOCIATES
$6K
10
AARIA PHARMACEUTICALS PVT LTD
$3K
11
RMPL PHARMA LLP
$2K
12
ILMIC HEALTH CARE PVT LTD
$2K
13
SAYAR LIFE-CARE
$2K
14
KHATU ENTERPRISES
$858.12
15
RUN MEDWAY
$593.86
16
KOBUN TECHNO PHARMA (OPC) PVT LTD
$326.38
17
AMARI TRADE ALLIANCE LLP
$292.50
18
J.A. UNITED EXPORTS PVT LTD
$243.01
19
M T MADON EXPORTS
$216.57
20
MELON GLOBALCARE
$69.59
21
VEA IMPEX (I) PVT LTD
$31.01
Top 17 Africa importers
1
CENTRAL MEDICAL STORES BOTSWANA · Botswana
$26K
2
PLANET PHARMACEUTICALS $ CHEMICALS · Zimbabwe
$25K
3
PHARM MEDICAL POST · Eswatini
$23K
4
BREVITEE INTERNATIONAL S.A · Equatorial Guinea
$13K
5
GOLD TREE PHARMACEUTICALS LTD · Kenya
$10K
6
GRIFFINS MEDICALS LTD · Zambia
$10K
7
GALAXY PHARMACEUTICAL LTD · Kenya
$8K
8
FOR THE ORDER OF · Zimbabwe
$7K
9
R PHARMA · Malawi
$6K
10
EHSAN COMERCIO GERL LDA · Angola
$2K
11
MINISTRY OF HEALTH ( CLAUDE JULIEN · Seychelles
$2K
12
OUMAR KONE · Mali
$858.12
13
NDZENGUE EBEDE JEAN JOEL · Cameroon
$593.86
14
ALCHEM INDUSTRIES S U R L · Burundi
$326.38
15
ABU AHMED · Kenya
$292.50
16
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Egypt
$243.01
17
MORAN PHARMACY LTD · Kenya
$216.57
Top 4 dosage forms
1
Injection
$152K
2
concentrate for solution for infusion
$12K
3
Solution
$10K
4
Vial
$9K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 32 | $83K | $3K |
| Dec | 37 | $100K | $3K |
Shipment register · 69 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — RELIANCE LIFE SCIENCES PVT LTD · 8 shipments · $77K | |||||||||||
| 1 | Nov 2025 | GALAXY PHARMACEUTICAL LTD | Kenya | Injection | 60 | VLS | $123.69 | $7K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 2 | Nov 2025 | GALAXY PHARMACEUTICAL LTD | Kenya | Injection | 24 | VLS | $30.45 | $730.70 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 3 | Nov 2025 | UNKNOWN BUYER | Kenya | Injection | 60 | VLS | $123.69 | $7K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Kenya | Injection | 24 | VLS | $30.45 | $730.70 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 5 | Nov 2025 | GRIFFINS MEDICALS LTD | Zambia | Solution | 100 | VLS | $19.16 | $2K | MUMBAI AIR (SAHAR) | LUSAKA | AIR |
| 6 | Nov 2025 | GRIFFINS MEDICALS LTD | Zambia | Solution | 100 | VLS | $76.65 | $8K | MUMBAI AIR (SAHAR) | LUSAKA | AIR |
| 7 | Dec 2025 | PLANET PHARMACEUTICALS $ CHEMICALS | Zimbabwe | Injection | 150 | VLS | $169.35 | $25K | MUMBAI AIR (SAHAR) | HARARE | AIR |
| 8 | Dec 2025 | CENTRAL MEDICAL STORES BOTSWANA | Botswana | Injection | 720 | VLS | $35.72 | $26K | MUMBAI AIR (SAHAR) | GABORONE | AIR |
| SUPPLIER #2 — INVEX HEALTH PVT LTD · 1 shipments · $23K | |||||||||||
| 9 | Nov 2025 | PHARM MEDICAL POST | Eswatini | Injection | 460 | NOS | $50.78 | $23K | MUMBAI AIR (SAHAR) | SOKCHO | AIR |
| SUPPLIER #3 — R.S. SURGIPHARM PVT LTD · 11 shipments · $19K | |||||||||||
| 10 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 1 | VLS | $16.57 | $16.57 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 11 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 2 | VLS | $16.57 | $33.13 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 12 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 10 | VLS | $16.57 | $165.67 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 13 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 17 | VLS | $16.57 | $281.65 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 14 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 40 | VLS | $68.07 | $3K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 15 | Dec 2025 | UNKNOWN BUYER | Kenya | concentrate for solution for infusion | 50 | VLS | $19.38 | $968.93 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 16 | Dec 2025 | UNKNOWN BUYER | Kenya | concentrate for solution for infusion | 20 | VLS | $76.80 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 17 | Dec 2025 | UNKNOWN BUYER | Kenya | concentrate for solution for infusion | 8 | VLS | $76.80 | $614.38 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 18 | Dec 2025 | UNKNOWN BUYER | Kenya | concentrate for solution for infusion | 80 | VLS | $76.80 | $6K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 19 | Dec 2025 | UNKNOWN BUYER | Kenya | concentrate for solution for infusion | 42 | VLS | $76.80 | $3K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 20 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 50 | VLS | $66.31 | $3K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #4 — PIRZE LIFECARE PVT LTD · 3 shipments · $13K | |||||||||||
| 21 | Dec 2025 | BREVITEE INTERNATIONAL S.A | Equatorial Guinea | Injection | 25 | NOS | $92.08 | $2K | AHMEDABAD AIR | MALABO | AIR |
| 22 | Dec 2025 | BREVITEE INTERNATIONAL S.A | Equatorial Guinea | Injection | 5 | NOS | $428.13 | $2K | AHMEDABAD AIR | MALABO | AIR |
| 23 | Dec 2025 | BREVITEE INTERNATIONAL S.A | Equatorial Guinea | Injection | 20 | NOS | $428.13 | $9K | AHMEDABAD AIR | MALABO | AIR |
| SUPPLIER #5 — ASPIDA LIFE SCIENCES PVT LTD · 3 shipments · $10K | |||||||||||
| 24 | Nov 2025 | GOLD TREE PHARMACEUTICALS LTD | Kenya | Injection | 10 | NOS | $59.80 | $598.01 | DELHI AIR | NAIROBI | AIR |
| 25 | Nov 2025 | GOLD TREE PHARMACEUTICALS LTD | Kenya | Injection | 10 | NOS | $152.49 | $2K | DELHI AIR | NAIROBI | AIR |
| 26 | Nov 2025 | GOLD TREE PHARMACEUTICALS LTD | Kenya | Injection | 50 | NOS | $159.47 | $8K | DELHI AIR | NAIROBI | AIR |
| SUPPLIER #6 — SANSKRUTI PHARMA · 10 shipments · $9K | |||||||||||
| 27 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 10 | VLS | $168.24 | $2K | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 28 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 7 | VLS | $69.27 | $484.92 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 29 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 10 | VLS | $161.76 | $2K | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 30 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 7 | VLS | $66.61 | $466.25 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 31 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Injection | 10 | VLS | $161.76 | $2K | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 32 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Injection | 7 | VLS | $66.61 | $466.25 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 33 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 10 | VLS | $161.75 | $2K | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 34 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 10 | VLS | $66.60 | $666.01 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 35 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Injection | 7 | VLS | $1.82 | $12.76 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 36 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Injection | 7 | VLS | $0.751 | $5.25 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #7 — SUBHRA PHARMA PRIAVATE LTD · 6 shipments · $7K | |||||||||||
| 37 | Nov 2025 | UNLISTED BUYER | Kenya | Vial | 30 | NOS | $59.16 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 38 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 30 | NOS | $59.23 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 39 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 30 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 40 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 35 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 41 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 30 | NOS | $58.59 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 42 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 35 | NOS | $58.59 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #8 — 3S PHARMACEUTICALS INDIA PVT LTD · 2 shipments · $7K | |||||||||||
| 43 | Nov 2025 | FOR THE ORDER OF | Zimbabwe | Injection | 30 | NOS | $31.20 | $935.96 | MUMBAI AIR (SAHAR) | HARARE | AIR |
| 44 | Nov 2025 | FOR THE ORDER OF | Zimbabwe | Injection | 50 | NOS | $122.12 | $6K | MUMBAI AIR (SAHAR) | HARARE | AIR |
| SUPPLIER #9 — MATHI ASSOCIATES · 3 shipments · $6K | |||||||||||
| 45 | Dec 2025 | R PHARMA | Malawi | Injection | 37 | NOS | $55.71 | $2K | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| 46 | Dec 2025 | R PHARMA | Malawi | Injection | 3 | NOS | $55.71 | $167.14 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| 47 | Dec 2025 | R PHARMA | Malawi | Injection | 60 | NOS | $55.71 | $3K | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| SUPPLIER #10 — AARIA PHARMACEUTICALS PVT LTD · 1 shipments · $3K | |||||||||||
| 48 | Nov 2025 | UNLISTED BUYER | Egypt | Injection | 50 | NOS | $53.84 | $3K | MUMBAI AIR (SAHAR) | ALEXANDRIA, EL NHOUZ | AIR |
| SUPPLIER #11 — RMPL PHARMA LLP · 3 shipments · $2K | |||||||||||
| 49 | Nov 2025 | UNLISTED BUYER | Kenya | Injection | 50 | NOS | $14.07 | $703.62 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 50 | Nov 2025 | UNLISTED BUYER | Kenya | Injection | 5 | NOS | $55.34 | $276.68 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 51 | Nov 2025 | UNLISTED BUYER | Kenya | Injection | 25 | NOS | $55.34 | $1K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #12 — ILMIC HEALTH CARE PVT LTD · 1 shipments · $2K | |||||||||||
| 52 | Dec 2025 | EHSAN COMERCIO GERL LDA | Angola | Injection | 30 | VLS | $76.30 | $2K | DELHI AIR | LUANDA - | AIR |
| SUPPLIER #13 — SAYAR LIFE-CARE · 1 shipments · $2K | |||||||||||
| 53 | Dec 2025 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | Vial | 24 | NOS | $71.30 | $2K | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #14 — KHATU ENTERPRISES · 3 shipments · $858.12 | |||||||||||
| 54 | Dec 2025 | OUMAR KONE | Mali | Injection | 7 | NOS | $18.61 | $130.30 | MUMBAI AIR (SAHAR) | BAMAKO | AIR |
| 55 | Dec 2025 | OUMAR KONE | Mali | Injection | 3 | NOS | $18.61 | $55.84 | MUMBAI AIR (SAHAR) | BAMAKO | AIR |
| 56 | Dec 2025 | OUMAR KONE | Mali | Injection | 10 | NOS | $67.20 | $671.98 | MUMBAI AIR (SAHAR) | BAMAKO | AIR |
| SUPPLIER #15 — RUN MEDWAY · 4 shipments · $593.86 | |||||||||||
| 57 | Nov 2025 | NDZENGUE EBEDE JEAN JOEL | Cameroon | Injection | 2 | NOS | $59.39 | $118.77 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 58 | Nov 2025 | NDZENGUE EBEDE JEAN JOEL | Cameroon | Injection | 3 | NOS | $59.39 | $178.16 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 59 | Nov 2025 | NDZENGUE EBEDE JEAN JOEL | Cameroon | Injection | 2 | NOS | $59.39 | $118.77 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 60 | Nov 2025 | NDZENGUE EBEDE JEAN JOEL | Cameroon | Injection | 3 | NOS | $59.39 | $178.16 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #16 — KOBUN TECHNO PHARMA (OPC) PVT LTD · 1 shipments · $326.38 | |||||||||||
| 61 | Dec 2025 | ALCHEM INDUSTRIES S U R L | Burundi | Injection | 4 | NOS | $81.59 | $326.38 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| SUPPLIER #17 — AMARI TRADE ALLIANCE LLP · 1 shipments · $292.50 | |||||||||||
| 62 | Nov 2025 | ABU AHMED | Kenya | Injection | 20 | VLS | $14.62 | $292.50 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #18 — J.A. UNITED EXPORTS PVT LTD · 2 shipments · $243.01 | |||||||||||
| 63 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | Injection | 290 | VLS | $0.728 | $211.06 | MUMBAI AIR (SAHAR) | CAIRO | AIR |
| 64 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | Injection | 166 | VLS | $0.192 | $31.95 | MUMBAI AIR (SAHAR) | CAIRO | AIR |
| SUPPLIER #19 — M T MADON EXPORTS · 1 shipments · $216.57 | |||||||||||
| 65 | Nov 2025 | MORAN PHARMACY LTD | Kenya | Injection | 15 | NOS | $14.44 | $216.57 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #20 — MELON GLOBALCARE · 1 shipments · $69.59 | |||||||||||
| 66 | Nov 2025 | UNLISTED BUYER | Cameroon | Injection | 6 | NOS | $11.60 | $69.59 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #21 — VEA IMPEX (I) PVT LTD · 3 shipments · $31.01 | |||||||||||
| 67 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 15 | NOS | $0.689 | $10.34 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 68 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 15 | NOS | $0.689 | $10.34 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 69 | Dec 2025 | UNLISTED BUYER | Somalia | Vial | 15 | NOS | $0.689 | $10.34 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
10 countries · 40 shipments · $444K · 12 Indian suppliers · 15 buyers
SHIPMENTS
40
USD
$444K
COUNTRIES
10
SUPPLIERS
12
BUYERS
15
HHI
6,315
concentrated
Top 10 destination countries in Asia
1
Lebanon (68.9%)
$306K
2
Nepal (6.9%)
$31K
3
Maldives (5.9%)
$26K
4
Sri Lanka (5.3%)
$24K
5
Turkey (4.9%)
$22K
6
Yemen (4.9%)
$22K
7
Afghanistan (1.6%)
$7K
8
Philippines (0.9%)
$4K
9
United Arab Emirates (0.6%)
$3K
10
Laos (0.0%)
$44.54
Top 12 Indian suppliers into Asia
1
RELIANCE LIFE SCIENCES PVT LTD
$350K
2
RMPL PHARMA LLP
$32K
3
DRREDDYS LABORATORIES LTD
$26K
4
J.A. UNITED EXPORTS PVT LTD
$22K
5
KERK
$7K
6
MALLESHWAR SPECIALITIES
$4K
7
PLEASANT EXPORTS
$2K
8
MEDMATRIX ASSOCIATES
$592.24
9
SEATRACK INTERNATIONAL TRADEX PVT LTD
$504.68
10
NU HOSPITALS PVT LTD
$447.04
11
AMARI TRADE ALLIANCE LLP
$281.81
12
SPECTRA DISTRIBUTORS
$44.54
Top 13 Asia importers
1
LEVANT PULSE · Lebanon
$297K
2
PHARMACHEM PVT LTD · Nepal
$31K
3
STATE TRADING ORGANIZATION PLC · Maldives
$26K
4
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Yemen
$22K
5
ABC PHARMA SERVICES (PVT) LTD · Sri Lanka
$10K
6
ETEMAD MOSLEH LTD · Afghanistan
$7K
7
ABC PHARMA SERVICES [PVT] LTD · Sri Lanka
$6K
8
RENATO C LOZADA · Philippines
$4K
9
THE ESSES PHARMACY (PVT) LTD · Sri Lanka
$2K
10
GULF IMPEX FZC · Afghanistan
$592.24
11
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$504.68
12
INDIRA GANDHI MEMOROAL HOSPITAL · Maldives
$447.04
13
ABU ABDU · Turkey
$281.81
Top 2 dosage forms
1
Solution
$297K
2
Injection
$147K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $30K | $6K |
| Nov | 19 | $355K | $19K |
| Dec | 16 | $59K | $4K |
Shipment register · 40 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — RELIANCE LIFE SCIENCES PVT LTD · 10 shipments · $350K | |||||||||||
| 1 | Nov 2025 | PHARMACHEM PVT LTD | Nepal | Injection | 100 | NOS | $28.19 | $3K | RAXAUL | Birgunj | ROAD |
| 2 | Nov 2025 | PHARMACHEM PVT LTD | Nepal | Injection | 300 | NOS | $93.02 | $28K | RAXAUL | Birgunj | ROAD |
| 3 | Nov 2025 | ABC PHARMA SERVICES [PVT] LTD | Sri Lanka | Injection | 50 | VLS | $17.44 | $871.87 | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 4 | Nov 2025 | ABC PHARMA SERVICES [PVT] LTD | Sri Lanka | Injection | 100 | VLS | $51.84 | $5K | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | Sri Lanka | Injection | 50 | VLS | $17.44 | $871.87 | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 6 | Nov 2025 | UNKNOWN BUYER | Sri Lanka | Injection | 100 | VLS | $51.84 | $5K | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 7 | Nov 2025 | LEVANT PULSE | Lebanon | Solution | 500 | VLS | $19.97 | $10K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 8 | Nov 2025 | LEVANT PULSE | Lebanon | Solution | 4.2K | VLS | $19.98 | $84K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 9 | Nov 2025 | LEVANT PULSE | Lebanon | Solution | 3.7K | VLS | $54.94 | $203K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 10 | Dec 2025 | ABC PHARMA SERVICES (PVT) LTD | Sri Lanka | Injection | 200 | VLS | $47.68 | $10K | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| SUPPLIER #2 — RMPL PHARMA LLP · 14 shipments · $32K | |||||||||||
| 11 | Nov 2025 | UNLISTED BUYER | Lebanon | Injection | 50 | NOS | $10.89 | $544.33 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 12 | Nov 2025 | UNLISTED BUYER | Lebanon | Injection | 40 | NOS | $44.93 | $2K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 13 | Nov 2025 | UNLISTED BUYER | Lebanon | Injection | 60 | NOS | $44.93 | $3K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 14 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 10 | NOS | $58.19 | $581.94 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 15 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 10 | NOS | $58.19 | $581.94 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 16 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Injection | 10 | NOS | $58.19 | $581.94 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 17 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Injection | 10 | NOS | $58.19 | $581.94 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 18 | Nov 2025 | UNLISTED BUYER | Turkey | Injection | 100 | NOS | $60.75 | $6K | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 19 | Dec 2025 | UNLISTED BUYER | Lebanon | Injection | 1 | NOS | $15.08 | $15.08 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 20 | Dec 2025 | UNLISTED BUYER | Lebanon | Injection | 29 | NOS | $15.07 | $437.15 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 21 | Dec 2025 | UNLISTED BUYER | Lebanon | Injection | 50 | NOS | $61.13 | $3K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 22 | Dec 2025 | UNLISTED BUYER | Turkey | Injection | 30 | NOS | $0.137 | $4.10 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 23 | Dec 2025 | UNLISTED BUYER | Lebanon | Injection | 50 | NOS | $0.674 | $33.72 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 24 | Dec 2025 | UNLISTED BUYER | Turkey | Injection | 300 | NOS | $51.64 | $15K | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #3 — DRREDDYS LABORATORIES LTD · 1 shipments · $26K | |||||||||||
| 25 | Oct 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Injection | 200 | NOS | $127.89 | $26K | HYDERABAD AIR | MALE | AIR |
| SUPPLIER #4 — J.A. UNITED EXPORTS PVT LTD · 2 shipments · $22K | |||||||||||
| 26 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 290 | VLS | $65.21 | $19K | MUMBAI AIR (SAHAR) | ADEN | AIR |
| 27 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 166 | VLS | $17.25 | $3K | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #5 — KERK · 2 shipments · $7K | |||||||||||
| 28 | Dec 2025 | ETEMAD MOSLEH LTD | Afghanistan | Injection | 82 | NOS | $14.24 | $1K | DELHI AIR | KABUL | AIR |
| 29 | Dec 2025 | ETEMAD MOSLEH LTD | Afghanistan | Injection | 100 | NOS | $54.60 | $5K | DELHI AIR | KABUL | AIR |
| SUPPLIER #6 — MALLESHWAR SPECIALITIES · 3 shipments · $4K | |||||||||||
| 30 | Oct 2025 | RENATO C LOZADA | Philippines | Injection | 41 | NOS | $74.03 | $3K | BANGALORE AIR | MANILA | AIR |
| 31 | Oct 2025 | RENATO C LOZADA | Philippines | Injection | 9 | NOS | $74.03 | $666.28 | BANGALORE AIR | MANILA | AIR |
| 32 | Oct 2025 | RENATO C LOZADA | Philippines | Injection | 20 | NOS | $21.64 | $432.80 | BANGALORE AIR | MANILA | AIR |
| SUPPLIER #7 — PLEASANT EXPORTS · 2 shipments · $2K | |||||||||||
| 33 | Nov 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Injection | 10 | NOS | $115.93 | $1K | CHENNAI AIR | COLOMBO | AIR |
| 34 | Dec 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Injection | 20 | NOS | $35.44 | $708.70 | CHENNAI AIR | COLOMBO | AIR |
| SUPPLIER #8 — MEDMATRIX ASSOCIATES · 1 shipments · $592.24 | |||||||||||
| 35 | Dec 2025 | GULF IMPEX FZC | Afghanistan | Injection | 100 | NOS | $5.92 | $592.24 | DADRI ICD | KABUL | ICD |
| SUPPLIER #9 — SEATRACK INTERNATIONAL TRADEX PVT LTD · 1 shipments · $504.68 | |||||||||||
| 36 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Injection | 10 | NOS | $50.47 | $504.68 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #10 — NU HOSPITALS PVT LTD · 1 shipments · $447.04 | |||||||||||
| 37 | Oct 2025 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | Injection | 2 | NOS | $223.52 | $447.04 | BANGALORE AIR | MALE | AIR |
| SUPPLIER #11 — AMARI TRADE ALLIANCE LLP · 2 shipments · $281.81 | |||||||||||
| 38 | Dec 2025 | ABU ABDU | Turkey | Injection | 200 | NOS | $0.517 | $103.42 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 39 | Dec 2025 | ABU ABDU | Turkey | Injection | 300 | NOS | $0.595 | $178.39 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #12 — SPECTRA DISTRIBUTORS · 1 shipments · $44.54 | |||||||||||
| 40 | Nov 2025 | UNKNOWN BUYER | Laos | Injection | 5 | NOS | $8.91 | $44.54 | MUMBAI AIR (SAHAR) | VIENTIANE | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
2 countries · 5 shipments · $861K · 3 Indian suppliers · 3 buyers
SHIPMENTS
5
USD
$861K
COUNTRIES
2
SUPPLIERS
3
BUYERS
3
HHI
9,932
concentrated
Top 2 destination countries in Europe
1
Russia (99.8%)
$859K
2
Germany (0.2%)
$2K
Top 3 Indian suppliers into Europe
1
DRREDDYS LABORATORIES LTD
$858K
2
SACRED LEAVES PVT LTD
$2K
3
CHINTAN CHEMICALS
$1K
Top 3 Europe importers
1
JSC R-PHARM · Russia
$858K
2
SOVEREIGN SPEED FRA GMBH · Germany
$2K
3
JSC GENERIUM · Russia
$1K
Top 2 dosage forms
1
Solution
$858K
2
Injection
$3K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $858K | $858K |
| Nov | 4 | $3K | $738.36 |
| Dec | 0 | $0.0000 | — |
Shipment register · 5 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — DRREDDYS LABORATORIES LTD · 1 shipments · $858K | |||||||||||
| 1 | Oct 2025 | JSC R-PHARM | Russia | Solution | 2.3K | GMS | $370.76 | $858K | HYDERABAD AIR | MOSCOW DOMODEDOVO | AIR |
| SUPPLIER #2 — SACRED LEAVES PVT LTD · 3 shipments · $2K | |||||||||||
| 2 | Nov 2025 | SOVEREIGN SPEED FRA GMBH | Germany | Injection | 15 | PCS | $0.0000 | $0.0000 | DELHI AIR | FRANKFURT/MAIN INT'L | AIR |
| 3 | Nov 2025 | SOVEREIGN SPEED FRA GMBH | Germany | Injection | 15 | PCS | $0.0000 | $0.0000 | DELHI AIR | FRANKFURT/MAIN INT'L | AIR |
| 4 | Nov 2025 | SOVEREIGN SPEED FRA GMBH | Germany | Injection | 15 | PCS | $116.99 | $2K | DELHI AIR | FRANKFURT/MAIN INT'L | AIR |
| SUPPLIER #3 — CHINTAN CHEMICALS · 1 shipments · $1K | |||||||||||
| 5 | Nov 2025 | JSC GENERIUM | Russia | Injection | 20 | NOS | $59.93 | $1K | AHMEDABAD AIR | MOSCOW | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
9 countries · 23 shipments · $259K · 7 Indian suppliers · 10 buyers
SHIPMENTS
23
USD
$259K
COUNTRIES
9
SUPPLIERS
7
BUYERS
10
HHI
9,339
concentrated
Top 9 destination countries in Americas
1
Peru (68.4%)
$177K
2
Colombia (25.4%)
$66K
3
Dominican Republic (2.8%)
$7K
4
Brazil (1.7%)
$4K
5
Saint Kitts and Nevis (0.8%)
$2K
6
Mexico (0.5%)
$1K
7
Antigua and Barbuda (0.3%)
$820.72
8
United States (0.1%)
$134.76
9
Dominica (0.0%)
$8.11
Top 7 Indian suppliers into Americas
1
RELIANCE LIFE SCIENCES PVT LTD
$251K
2
NIVIRA EXPORTS
$4K
3
SPR ONCOCARE PVT LTD
$2K
4
VAMA HEALTH WORLD LLP
$1K
5
VEA IMPEX (I) PVT LTD
$828.83
6
DRREDDYS LABORATORIES LTD
$134.76
7
ATLAS ENTERPRISES
$77.45
Top 8 Americas importers
1
DROGUERIA MK LAB S.A · Peru
$177K
2
LABORATORIOS LEGRAND S.A · Colombia
$66K
3
SEAN DOMINICAN SRL · Dominican Republic
$7K
4
FELICIA CARLOS DE ARAUJO MAIA · Brazil
$4K
5
AS PER INVOICE MEXICO · Mexico
$1K
6
WELLPOINT MEDICAL & ONCOLOGY CENTER · Saint Kitts and Nevis
$982.32
7
CHARLES RIVER LABORATORIES INC · United States
$134.76
8
DISTRIBUIDORA MEDICA PAREDES S.DE R · Mexico
$77.45
Top 6 dosage forms
1
Injection
$252K
2
Liquid
$4K
3
Unknown
$1K
4
mg
$491.16
5
Vial
$418.47
6
bulk
$134.76
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $134.76 | $67.38 |
| Nov | 13 | $253K | $19K |
| Dec | 8 | $6K | $741.39 |
Shipment register · 23 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — RELIANCE LIFE SCIENCES PVT LTD · 9 shipments · $251K | |||||||||||
| 1 | Nov 2025 | SEAN DOMINICAN SRL | Dominican Republic | Injection | 50 | VLS | $24.56 | $1K | MUMBAI AIR (SAHAR) | SANTO DOMINGO | AIR |
| 2 | Nov 2025 | SEAN DOMINICAN SRL | Dominican Republic | Injection | 100 | VLS | $58.95 | $6K | MUMBAI AIR (SAHAR) | SANTO DOMINGO | AIR |
| 3 | Nov 2025 | DROGUERIA MK LAB S.A | Peru | Injection | 909 | VLS | $14.45 | $13K | MUMBAI AIR (SAHAR) | LIMA - | AIR |
| 4 | Nov 2025 | DROGUERIA MK LAB S.A | Peru | Injection | 2.3K | VLS | $72.24 | $164K | MUMBAI AIR (SAHAR) | LIMA - | AIR |
| 5 | Nov 2025 | DROGUERIA MK LAB S.A | Peru | Injection | 1 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | LIMA - | AIR |
| 6 | Nov 2025 | DROGUERIA MK LAB S.A | Peru | Injection | 1 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | LIMA - | AIR |
| 7 | Nov 2025 | LABORATORIOS LEGRAND S.A | Colombia | Injection | 3.0K | VLS | $21.97 | $66K | MUMBAI AIR (SAHAR) | BOGOTA | AIR |
| 8 | Dec 2025 | SEAN DOMINICAN SRL | Dominican Republic | Injection | 100 | VLS | $0.665 | $66.51 | MUMBAI AIR (SAHAR) | SANTO DOMINGO | AIR |
| 9 | Dec 2025 | SEAN DOMINICAN SRL | Dominican Republic | Injection | 50 | VLS | $0.277 | $13.86 | MUMBAI AIR (SAHAR) | SANTO DOMINGO | AIR |
| SUPPLIER #2 — NIVIRA EXPORTS · 1 shipments · $4K | |||||||||||
| 10 | Dec 2025 | FELICIA CARLOS DE ARAUJO MAIA | Brazil | Liquid | 6 | VLS | $739.86 | $4K | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
| SUPPLIER #3 — SPR ONCOCARE PVT LTD · 4 shipments · $2K | |||||||||||
| 11 | Nov 2025 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 6 | NOS | $81.86 | $491.16 | BANGALORE AIR | NEVIS | AIR | |
| 12 | Nov 2025 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 6 | NOS | $81.86 | $491.16 | BANGALORE AIR | NEVIS | AIR | |
| 13 | Nov 2025 | UNKNOWN BUYER | Saint Kitts and Nevis | mg | 6 | NOS | $81.86 | $491.16 | BANGALORE AIR | NEVIS | AIR |
| 14 | Nov 2025 | UNKNOWN BUYER | Saint Kitts and Nevis | 6 | NOS | $81.86 | $491.16 | BANGALORE AIR | NEVIS | AIR | |
| SUPPLIER #4 — VAMA HEALTH WORLD LLP · 2 shipments · $1K | |||||||||||
| 15 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Injection | 10 | NOS | $16.33 | $163.28 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 16 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Injection | 15 | NOS | $77.51 | $1K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #5 — VEA IMPEX (I) PVT LTD · 3 shipments · $828.83 | |||||||||||
| 17 | Nov 2025 | UNLISTED BUYER | Antigua and Barbuda | Injection | 6 | NOS | $68.39 | $410.36 | MUMBAI AIR (SAHAR) | ANTIGUA | AIR |
| 18 | Nov 2025 | UNLISTED BUYER | Antigua and Barbuda | Vial | 6 | NOS | $68.39 | $410.36 | MUMBAI AIR (SAHAR) | ANTIGUA | AIR |
| 19 | Dec 2025 | UNLISTED BUYER | Dominica | Vial | 8 | NOS | $1.01 | $8.11 | MUMBAI AIR (SAHAR) | DOMINICA | AIR |
| SUPPLIER #6 — DRREDDYS LABORATORIES LTD · 2 shipments · $134.76 | |||||||||||
| 20 | Oct 2025 | CHARLES RIVER LABORATORIES INC | United States | bulk | 32 | NOS | $3.96 | $126.83 | HYDERABAD AIR | NEW YORK - JOHN F. K | AIR |
| 21 | Oct 2025 | CHARLES RIVER LABORATORIES INC | United States | bulk | 8 | NOS | $0.991 | $7.93 | HYDERABAD AIR | NEW YORK - JOHN F. K | AIR |
| SUPPLIER #7 — ATLAS ENTERPRISES · 2 shipments · $77.45 | |||||||||||
| 22 | Dec 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | Injection | 20 | NOS | $0.968 | $19.36 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 23 | Dec 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | Injection | 60 | NOS | $0.968 | $58.09 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 35 Indian rituximab exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped rituximab in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | DRREDDYS LABORATORIES LTD | HYDERABAD | 4 | $883K | Solution, Injection, bulk | Europe, Asia |
| 2 | RELIANCE LIFE SCIENCES PVT LTD | NAVI MUMBAI MAHARASHTRA | 27 | $677K | Injection, Solution | Asia, Africa |
| 3 | RMPL PHARMA LLP | MUMBAI | 17 | $35K | Injection | Asia, Africa |
| 4 | INVEX HEALTH PVT LTD | MUMBAI | 1 | $23K | Injection | Africa |
| 5 | J.A. UNITED EXPORTS PVT LTD | VASHI | 4 | $22K | Injection | Asia, Africa |
| 6 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 11 | $19K | Injection, concentrate for solution for infusion | Africa |
| 7 | PIRZE LIFECARE PVT LTD | AHMEDABAD | 3 | $13K | Injection | Africa |
| 8 | ASPIDA LIFE SCIENCES PVT LTD | GHAZIABAD | 3 | $10K | Injection | Africa |
| 9 | SANSKRUTI PHARMA | SURAT | 10 | $9K | Injection | Africa |
| 10 | SUBHRA PHARMA PRIAVATE LTD | Navghar Mulund East Mumbai | 6 | $7K | Vial | Africa |
| 11 | 3S PHARMACEUTICALS INDIA PVT LTD | MUMBAI | 2 | $7K | Injection | Africa |
| 12 | KERK | DELHI | 2 | $7K | Injection | Asia |
| 13 | MATHI ASSOCIATES | MUMBAI | 3 | $6K | Injection | Africa |
| 14 | NIVIRA EXPORTS | MUMBAI | 1 | $4K | Liquid | Americas |
| 15 | MALLESHWAR SPECIALITIES | BANGALORE | 3 | $4K | Injection | Asia |
| 16 | AARIA PHARMACEUTICALS PVT LTD | VADODARA | 1 | $3K | Injection | Africa |
| 17 | ILMIC HEALTH CARE PVT LTD | NEW DELHI | 1 | $2K | Injection | Africa |
| 18 | SPR ONCOCARE PVT LTD | BANGALORE | 4 | $2K | mg | Americas |
| 19 | PLEASANT EXPORTS | CHENNAI | 2 | $2K | Injection | Asia |
| 20 | SACRED LEAVES PVT LTD | NEW DELHI | 3 | $2K | Injection | Europe |
| 21 | SAYAR LIFE-CARE | Chennai | 1 | $2K | Vial | Africa |
| 22 | VAMA HEALTH WORLD LLP | Mumbai | 2 | $1K | Injection | Americas |
| 23 | CHINTAN CHEMICALS | AHMEDABAD | 1 | $1K | Injection | Europe |
| 24 | VEA IMPEX (I) PVT LTD | MUMBAI | 6 | $859.83 | Injection, Vial | Americas, Africa |
| 25 | KHATU ENTERPRISES | NAGPUR | 3 | $858.12 | Injection | Africa |
| 26 | RUN MEDWAY | SURAT | 4 | $593.86 | Injection | Africa |
| 27 | MEDMATRIX ASSOCIATES | AMBALA | 1 | $592.24 | Injection | Asia |
| 28 | AMARI TRADE ALLIANCE LLP | MUMBAI | 3 | $574.31 | Injection | Africa, Asia |
| 29 | SEATRACK INTERNATIONAL TRADEX PVT LTD | NEW DELHI | 1 | $504.68 | Injection | Asia |
| 30 | NU HOSPITALS PVT LTD | BENGALURU | 1 | $447.04 | Injection | Asia |
| 31 | KOBUN TECHNO PHARMA (OPC) PVT LTD | RANCI | 1 | $326.38 | Injection | Africa |
| 32 | M T MADON EXPORTS | MUMBAI | 1 | $216.57 | Injection | Africa |
| 33 | ATLAS ENTERPRISES | NAGPUR | 2 | $77.45 | Injection | Americas |
| 34 | MELON GLOBALCARE | MUMBAI | 1 | $69.59 | Injection | Africa |
| 35 | SPECTRA DISTRIBUTORS | NAGPUR | 1 | $44.54 | Injection | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 40 global rituximab importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian rituximab in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | JSC R-PHARM | Russia | 1 | $858K | DRREDDYS LABORATORIE… | Solution |
| 2 | LEVANT PULSE | Lebanon | 3 | $297K | RELIANCE LIFE SCIENC… | Solution |
| 3 | DROGUERIA MK LAB S.A | Peru | 4 | $177K | RELIANCE LIFE SCIENC… | Injection |
| 4 | LABORATORIOS LEGRAND S.A | Colombia | 1 | $66K | RELIANCE LIFE SCIENC… | Injection |
| 5 | PHARMACHEM PVT LTD | Nepal | 2 | $31K | RELIANCE LIFE SCIENC… | Injection |
| 6 | CENTRAL MEDICAL STORES BOTSWANA | Botswana | 1 | $26K | RELIANCE LIFE SCIENC… | Injection |
| 7 | STATE TRADING ORGANIZATION PLC | Maldives | 1 | $26K | DRREDDYS LABORATORIE… | Injection |
| 8 | PLANET PHARMACEUTICALS $ CHEMICALS | Zimbabwe | 1 | $25K | RELIANCE LIFE SCIENC… | Injection |
| 9 | PHARM MEDICAL POST | Eswatini | 1 | $23K | INVEX HEALTH PVT LTD | Injection |
| 10 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | 4 | $22K | J.A. UNITED EXPORTS … | Injection |
| 11 | BREVITEE INTERNATIONAL S.A | Equatorial Guinea | 3 | $13K | PIRZE LIFECARE PVT LTD | Injection |
| 12 | GOLD TREE PHARMACEUTICALS LTD | Kenya | 3 | $10K | ASPIDA LIFE SCIENCES… | Injection |
| 13 | GRIFFINS MEDICALS LTD | Zambia | 2 | $10K | RELIANCE LIFE SCIENC… | Solution |
| 14 | ABC PHARMA SERVICES (PVT) LTD | Sri Lanka | 1 | $10K | RELIANCE LIFE SCIENC… | Injection |
| 15 | GALAXY PHARMACEUTICAL LTD | Kenya | 2 | $8K | RELIANCE LIFE SCIENC… | Injection |
| 16 | SEAN DOMINICAN SRL | Dominican Republic | 4 | $7K | RELIANCE LIFE SCIENC… | Injection |
| 17 | FOR THE ORDER OF | Zimbabwe | 2 | $7K | 3S PHARMACEUTICALS I… | Injection |
| 18 | ETEMAD MOSLEH LTD | Afghanistan | 2 | $7K | KERK | Injection |
| 19 | ABC PHARMA SERVICES [PVT] LTD | Sri Lanka | 2 | $6K | RELIANCE LIFE SCIENC… | Injection |
| 20 | R PHARMA | Malawi | 3 | $6K | MATHI ASSOCIATES | Injection |
| 21 | FELICIA CARLOS DE ARAUJO MAIA | Brazil | 1 | $4K | NIVIRA EXPORTS | Liquid |
| 22 | RENATO C LOZADA | Philippines | 3 | $4K | MALLESHWAR SPECIALIT… | Injection |
| 23 | EHSAN COMERCIO GERL LDA | Angola | 1 | $2K | ILMIC HEALTH CARE PV… | Injection |
| 24 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | 2 | $2K | PLEASANT EXPORTS | Injection |
| 25 | SOVEREIGN SPEED FRA GMBH | Germany | 3 | $2K | SACRED LEAVES PVT LTD | Injection |
| 26 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | 1 | $2K | SAYAR LIFE-CARE | Vial |
| 27 | AS PER INVOICE MEXICO | Mexico | 2 | $1K | VAMA HEALTH WORLD LLP | Injection |
| 28 | JSC GENERIUM | Russia | 1 | $1K | CHINTAN CHEMICALS | Injection |
| 29 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 2 | $982.32 | SPR ONCOCARE PVT LTD | |
| 30 | OUMAR KONE | Mali | 3 | $858.12 | KHATU ENTERPRISES | Injection |
| 31 | NDZENGUE EBEDE JEAN JOEL | Cameroon | 4 | $593.86 | RUN MEDWAY | Injection |
| 32 | GULF IMPEX FZC | Afghanistan | 1 | $592.24 | MEDMATRIX ASSOCIATES | Injection |
| 33 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 1 | $504.68 | SEATRACK INTERNATION… | Injection |
| 34 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | 1 | $447.04 | NU HOSPITALS PVT LTD | Injection |
| 35 | ALCHEM INDUSTRIES S U R L | Burundi | 1 | $326.38 | KOBUN TECHNO PHARMA … | Injection |
| 36 | ABU AHMED | Kenya | 1 | $292.50 | AMARI TRADE ALLIANCE… | Injection |
| 37 | ABU ABDU | Turkey | 2 | $281.81 | AMARI TRADE ALLIANCE… | Injection |
| 38 | MORAN PHARMACY LTD | Kenya | 1 | $216.57 | M T MADON EXPORTS | Injection |
| 39 | CHARLES RIVER LABORATORIES INC | United States | 2 | $134.76 | DRREDDYS LABORATORIE… | bulk |
| 40 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | 2 | $77.45 | ATLAS ENTERPRISES | Injection |
This report covers 137 2025-Q4 Rituximab shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/rituximab
Talk to our trade analyst
Need a custom rituximab report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/rituximab
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Rituximab product page
Live data, supplier directory, price trends, and trade route analysis